Document Detail


Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen).
MedLine Citation:
PMID:  23229784     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
When herbal products are used in combination therapy with drugs, alterations in pharmacokinetics, pharmacodynamics, and toxicity can result. Many active components of herbal products are organic anions, and human organic anion transporter 1 (hOAT1, SLC22A6), hOAT3 (SLC22A8), and hOAT4 (SLC22A11) have been identified as potential sites of drug-drug interactions. Therefore, we assessed the effects of lithospermic acid (LSA), rosmarinic acid (RMA), salvianolic acid A (SAA), salvianolic acid B (SAB), and tanshinol (TSL), components of the herbal medicine Danshen, on the function of these transporters. Kinetic analysis demonstrated a competitive mechanism of inhibition for all five. K(i) values (μM) were estimated as 20.8±2.1 (LSA), 0.35±0.06 (RMA), 5.6±0.3 (SAA), 22.2±1.9 (SAB), and 40.4±12.9 (TSL) on hOAT1 and as 0.59±0.26 (LSA), 0.55±0.25 (RMA), 0.16±0.03 (SAA), 19.8±8.4 (SAB), and 8.6±3.3 (TSL) on hOAT3. No significant inhibition of hOAT4 activity by TSL was observed. Using published human pharmacokinetic values, unbound C(max)/K(i) ratios were calculated as an indicator of in vivo drug-drug interaction potential. Analysis indicated a strong interaction potential for RMA and TSL on both hOAT1 and hOAT3 and for LSA on hOAT3. Thus, herb-drug interactions may occur in vivo in situations of co-administration of Danshen and clinical therapeutics known to be hOAT1/hOAT3 substrates.
Authors:
Li Wang; Douglas H Sweet
Related Documents :
24146604 - Prediction of the p. falciparum target space relevant to malaria drug discovery.
8232984 - The potential for increasing seizure frequency, relapse, and appearance of new seizure ...
24974064 - Therapeutic advancements in juvenile idiopathic arthritis.
22935104 - In silico drug repositioning - what we need to know.
8828014 - Methods of managing levodopa-induced dyskinesias.
2692934 - Antimicrobial therapy in neonates, infants and children.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-11
Journal Detail:
Title:  Drug metabolism and pharmacokinetics     Volume:  -     ISSN:  1880-0920     ISO Abbreviation:  Drug Metab. Pharmacokinet.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101164773     Medline TA:  Drug Metab Pharmacokinet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pharmaceutics, Virginia Commonwealth University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytotoxic effects of benzbromarone and its 1'-hydroxy metabolite in human hepatocarcinoma FLC4 cells...
Next Document:  Longitudinal associations between binge eating and overeating and adverse outcomes among adolescents...